Annual Total Liabilities
$376.64 M
+$1.82 M+0.48%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual total liabilities is $376.64 million, with the most recent change of +$1.82 million (+0.48%) on December 31, 2023.
- During the last 3 years, KPTI annual total liabilities has risen by +$114.14 million (+43.48%).
- KPTI annual total liabilities is now -2.16% below its all-time high of $384.98 million, reached on December 31, 2021.
Performance
KPTI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$349.12 M
+$3.01 M+0.87%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly total liabilities is $349.12 million, with the most recent change of +$3.01 million (+0.87%) on September 30, 2024.
- Over the past year, KPTI quarterly total liabilities has increased by +$3.01 million (+0.87%).
- KPTI quarterly total liabilities is now -9.31% below its all-time high of $384.98 million, reached on December 31, 2021.
Performance
KPTI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
KPTI Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.5% | +0.9% |
| 3 y3 years | +43.5% | -8.1% |
| 5 y5 years | +138.3% | +46.8% |
KPTI Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.2% | +0.5% | -9.3% | +0.9% |
| 5 y | 5-year | -2.2% | +53.6% | -9.3% | +42.4% |
| alltime | all time | -2.2% | >+9999.0% | -9.3% | >+9999.0% |
Karyopharm Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $349.12 M(+0.9%) |
| Jun 2024 | - | $346.12 M(-7.3%) |
| Mar 2024 | - | $373.41 M(-0.9%) |
| Dec 2023 | $376.64 M(+0.5%) | $376.64 M(+1.7%) |
| Sep 2023 | - | $370.36 M(+0.3%) |
| Jun 2023 | - | $369.08 M(-0.5%) |
| Mar 2023 | - | $370.97 M(-1.0%) |
| Dec 2022 | $374.83 M(-2.6%) | $374.83 M(+0.9%) |
| Sep 2022 | - | $371.52 M(-0.3%) |
| Jun 2022 | - | $372.82 M(-1.1%) |
| Mar 2022 | - | $377.11 M(-2.0%) |
| Dec 2021 | $384.98 M(+46.7%) | $384.98 M(+1.3%) |
| Sep 2021 | - | $380.07 M(+2.8%) |
| Jun 2021 | - | $369.70 M(+17.5%) |
| Mar 2021 | - | $314.55 M(+19.8%) |
| Dec 2020 | $262.50 M(+7.1%) | $262.50 M(+3.4%) |
| Sep 2020 | - | $253.82 M(+1.4%) |
| Jun 2020 | - | $250.21 M(+0.1%) |
| Mar 2020 | - | $249.99 M(+2.0%) |
| Dec 2019 | $245.19 M(+55.2%) | $245.19 M(+3.1%) |
| Sep 2019 | - | $237.88 M(+52.8%) |
| Jun 2019 | - | $155.63 M(-6.2%) |
| Mar 2019 | - | $165.93 M(+5.0%) |
| Dec 2018 | $158.02 M | $158.02 M(+223.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $48.91 M(+13.4%) |
| Jun 2018 | - | $43.12 M(-15.2%) |
| Mar 2018 | - | $50.84 M(+0.0%) |
| Dec 2017 | $50.83 M(+180.2%) | $50.83 M(+125.0%) |
| Sep 2017 | - | $22.60 M(+18.7%) |
| Jun 2017 | - | $19.04 M(+11.5%) |
| Mar 2017 | - | $17.07 M(-5.9%) |
| Dec 2016 | $18.14 M(+6.2%) | $18.14 M(+8.7%) |
| Sep 2016 | - | $16.69 M(-3.7%) |
| Jun 2016 | - | $17.33 M(+14.8%) |
| Mar 2016 | - | $15.10 M(-11.6%) |
| Dec 2015 | $17.08 M(+26.1%) | $17.08 M(+4.3%) |
| Sep 2015 | - | $16.38 M(+2.6%) |
| Jun 2015 | - | $15.97 M(-3.3%) |
| Mar 2015 | - | $16.52 M(+21.9%) |
| Dec 2014 | $13.54 M(+311.4%) | $13.54 M(+84.2%) |
| Sep 2014 | - | $7.35 M(+22.5%) |
| Jun 2014 | - | $6.00 M(+15.7%) |
| Mar 2014 | - | $5.18 M(+57.5%) |
| Dec 2013 | $3.29 M(-88.7%) | $3.29 M(-96.8%) |
| Sep 2013 | - | $103.69 M(+3980.6%) |
| Jun 2013 | - | $2.54 M(-91.3%) |
| Dec 2012 | $29.19 M(+46.9%) | $29.19 M |
| Dec 2011 | $19.88 M | - |
FAQ
- What is Karyopharm Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual total liabilities year-on-year change?
- What is Karyopharm Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly total liabilities year-on-year change?
What is Karyopharm Therapeutics annual total liabilities?
The current annual total liabilities of KPTI is $376.64 M
What is the all time high annual total liabilities for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual total liabilities is $384.98 M
What is Karyopharm Therapeutics annual total liabilities year-on-year change?
Over the past year, KPTI annual total liabilities has changed by +$1.82 M (+0.48%)
What is Karyopharm Therapeutics quarterly total liabilities?
The current quarterly total liabilities of KPTI is $349.12 M
What is the all time high quarterly total liabilities for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly total liabilities is $384.98 M
What is Karyopharm Therapeutics quarterly total liabilities year-on-year change?
Over the past year, KPTI quarterly total liabilities has changed by +$3.01 M (+0.87%)